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Abstract Autocrine motility factor receptor (AMFR) is a cell
surface glycoprotein of molecular weight 78 000 (gp78), mediat-
ing cell motility signaling in vitro and metastasis in vivo. Here,
we cloned the full-length cDNAs for both human and mouse
AMFR genes. Both genes encode a protein of 643 amino acids
containing a seven transmembrane domain, a RING-H2 motif
and a leucine zipper motif and showed a 94.7% amino acid
sequence identity to each other. Analysis of the amino acid
sequence of AMFR with protein databases revealed no
significant homology with all known seven transmembrane
proteins, but a significant structural similarity to a hypothetical
protein of Caenorhabditis elegans, F26E4.11. Thus, AMFR is a
highly conserved gene which encodes a novel type of seven
transmembrane protein.
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1. Introduction
Autocrine motility factor (AMF) is a tumor secreted mo-
lecular weight 55 000 cytokine that regulates cell motility in
vitro as well as invasion and metastasis in vivo [1]. Recent
studies have demonstrated that mouse and human AMFs are
identical to the products of previously cloned genes, neuro-
leukin (NLK) and phosphohexose isomerase (PHI). PHI cat-
alyzes isomerization of glucose 6-phosphate to fructose 6-
phosphate and is speci¢c for both sugars. Mouse AMF exhib-
its the enzymatic properties of PHI and rabbit heart PHI
stimulates the motility of mouse ¢brosarcoma cells similarly
to mouse AMF [2]. Recently, maturation factor (MF), which
mediates the di¡erentiation of human myeloid leukemic cells
to terminal monocytic cells, was also found to be identical to
PHI [3]. Thus, AMF, NLK, PHI and MF are single gene
products with pleotropic functions [4].
AMF stimulates random and directed cell motility via its
receptor. AMF receptor (AMFR) was identi¢ed as a 78 kDa
cell surface glycoprotein (gp78) and a monoclonal antibody
against it stimulates cell motility in vitro and the metastatic
ability in vivo by mimicking the e¡ect of the AMF ligand
[5,6]. Moreover, it has been shown that increased expression
of AMFR correlates with a high incidence of recurrence and a
shortened survival in patients with bladder cancer, colorectal
cancer, oesophageal cancer and gastric cancer [7^10].
To elucidate the functional role of AMFR in cancer inva-
sion and metastasis, it is pertinent to isolate a mouse homo-
logue of the human AMFR gene to construct a mouse model
defective in the Amfr gene. We therefore cloned the full-length
cDNA for the mouse Amfr gene. In the process of this clon-
ing, we uncovered that the human AMFR cDNA reported
previously [11] was only the 3P-partial sequence of this gene.
Thus, we further isolated the full-length cDNA for the human
AMFR gene. Full-length cDNAs for the human and mouse
AMFR genes encode a seven transmembrane protein with a
RING-H2 motif and a leucine zipper motif and showed a
94.7% amino acid sequence identity with each other. Protein
sequence database analysis revealed that the AMFR protein
had no signi¢cant homology with registered protein sequences
including the ones of seven transmembrane protein, but a
signi¢cant structural similarity to a Caenorhabditis elegans
hypothetical protein, F26E4.11. Thus, the AMFR gene is an
evolutionarily conserved gene which encodes a novel type of
seven transmembrane protein having the RING-H2 and leu-
cine zipper motifs.
2. Materials and methods
2.1. Screening and isolation of cDNA clones
A mouse expressed sequence tag (EST) clone (GenBank accession
number AA260491) was ampli¢ed from mouse lung cDNA by using a
primer pair of 5P-TAATATTGCTGATGGCAGTC-3P and 5P-TCTA-
GGCGAGGACTGAGGTC-3P. A partial cDNA fragment of the hu-
man AMFR gene was ampli¢ed by reverse transcriptase-polymerase
chain reaction (RT-PCR) from mRNA of a DLD-1 colon cancer cell
line using a primer pair of 5P-GATGTGGCCCAGTACCTGCTCT-
CA-3P and 5P-ATTTGCAGTGTTTCTAAGGGGA-3P. The sequen-
ces of the primers were designed from those of two EST clones (Gen-
Bank accession numbers M62018 and AA479243), which showed
homologies with a mouse Amfr cDNA clone (GenBank accession
number AF124144) (Fig. 1). The PCR conditions used were as fol-
lows: 35 cycles of 94‡C for 30 s, 60‡C for 30 s and 72‡C for 2 min.
cDNA libraries from mouse lung, mouse testis and a HeLa cell line
were used to isolate full-length cDNA clones. Isolated clones were
sequenced by the A.L.F. DNAsequencer II with the AutoRead Se-
quencing kit (Amersham Pharmacia Biotech, Upsala, Sweden).
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2.2. Homology search and analyses of nucleotide and amino acid
sequences
Sequence homologies of nucleotides and predicted amino acids were
analyzed through the GenomNet WWW server using BLASTN,
BLASTX and BLASTP searches of the non-redundant database
[12]. Predictions of transmembrane regions were performed through
the GenomNet WWW server using the SOSUI program.
2.3. Northern blot analysis
Mouse multiple tissue Northern (MTN) blot, containing 2 Wg of
poly (A)+ RNA from a variety of organs, was obtained from Clon-
tech (Palo Alto, CA, USA).
Northern blot hybridization was performed under the stringent
conditions as described previously [13]. Filter was hybridized with a
DNA probe corresponding to bases 1120^2333 of the cloned Amfr
cDNA fragment.
2.4. Chromosome mapping of the mouse Amfr gene
An interspeci¢c backcross panel generated from (C3H/HeJUMus
spretus) F1UC3H/HeJ was used for mapping of the mouse Amfr gene
locus [14]. Genotypes of Amfr for 134 individuals in this panel were
determined by a restriction fragment length polymorphism (RFLP)
observed in the PCR product of 740 bp in size that was ampli¢ed
from the 3P-non-coding region of the gene. An RFLP between the two
mouse strains SEG (M. spretus) and C3H/HeJ was identi¢ed by using
the XbaI enzyme. The sequences of the primers were 5P-GACATT-
TCTCTTCCCCTTAG-3P and 5P-TAATGAGACCCACAGGAACA-
3P, corresponding to nucleotides 2465^2485 and 3185^3205, respec-
tively. Mapping was carried out by analyzing the segregation of these
variants relative to known markers. The data generated in this study
were analyzed by Map Manager Version 2.5.6 [15].
3. Results
3.1. Isolation and characterization of the human and mouse
AMFR genes
We searched for mouse ESTs homologous to the human
AMFR gene in the GenBank EST database. A mouse EST
clone (GenBank accession number AA260491) was identi¢ed
as having an 86% sequence homology with a cDNA clone of
the human AMFR gene (GenBank accession number L35233)
[16]. Thus, this EST was ampli¢ed by PCR from mouse lung
cDNA and used as a probe for the screening of mouse cDNA
libraries. Two independent clones, ML4 and MT68, were iso-
lated from mouse lung and testis cDNA libraries, respectively.
Sequence analysis revealed that ML4 and MT68 overlapped
and contained the entire sequence of AA260491. A contiguous
sequence of 3.5 kb was obtained from these clones and was
veri¢ed by RT-PCR and sequencing (GenBank Accession
number AF124144). The nucleotide sequence of AF124144
revealed 76% identity with that of L35233 and contained an
open reading frame (ORF) of 643 amino acids. However, the
ORF of the mouse cDNA clone, A124144, was markedly
di¡erent from that of L35233. The 3P-end of the ORF in
A124144 was partly matched to the 5P-end of the ORF in
L35233 (Fig. 1). Therefore, it was assumed that L35233 is a
partial sequence of the human AMFR cDNA. To explore
this, a cDNA clone of 3 kb insert, H7, was isolated from a
human HeLa cDNA library (GenBank accession number
AF124145) using a cDNA fragment of the human AMFR
gene as a probe. The H7 clone showed 88.3% identity with
the nucleotide sequence of the mouse cDNA and contained an
ORF of 643 amino acids showing a signi¢cant homology
(94.7% identity) with the mouse predicted amino acid se-
quence. Comparison of the nucleotide sequence of the H7
clone, AF124145, with that of the previously isolated clone,
L35233, revealed that there were four one base deletions and
two one base insertions in L35233, resulting in the frame-shift
of the ORF. Therefore, we concluded that the cDNA clones
isolated here are the full-length ones for both the mouse Amfr
and the human AMFR genes.
Hydrophobic analysis of the amino acid sequence encoded
by the human AMFR gene revealed a putative seven trans-
membrane domain topology (Fig. 2B and C). Sequence anal-
ysis also revealed the presence of a RING-H2 motif, which is
a zinc ¢nger variant [17], and a leucine zipper motif [18]. Fig.
2D shows an alignment of the RING-H2 motif in AMFR and
several other RING-H2 containing proteins. Furthermore,
AMFR protein included a potential N-glycosylation site and
several potential O-glycosylation sites (Fig. 2A and B), sup-
porting the previous ¢nding that gp78 is glycosylated with
both N- and O-glycosaccharides [19]. A putative seven trans-
membrane domain, RING-H2 motif, leucine zipper motif and
a potential N-glycosylation site were all conserved in the
mouse AMFR proteins (Fig. 2A and B).
3.2. Homology of the AMFR with C. elegans protein F26E4.11
Comparison of the protein encoded by the AMFR gene
with protein sequence databases showed no signi¢cant homol-
Fig. 1. cDNA structures for the mouse and human AMFR genes. Open boxes indicate a region of the ORFs of the AMFR genes. Filled boxes
indicate a mouse EST clone (GenBank accession number AA260491) and two human EST clones (GenBank accession number M62018 and
AA479243).
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ogy with any known proteins except a C. elegans hypothetical
protein F26E4.11 (GenBank accession number Z81070), that
was predicted from a computer analysis of contiguous nucleo-
tide sequences from chromosome I [20]. The amino acid se-
quence of F26E4.11 showed 23% identity and 43% similarity
with that of human AMFR protein (Fig. 2A). The hydropa-
thy pro¢le of F26E4.11 was extremely similar to those of the
human and mouse AMFR proteins and the RING-H2 motif
was also conserved in the F26E4.11 sequence (Fig. 2A, C and
D). This result indicates that F26E4.11 is a C. elegans homo-
logue of the human AMFR gene.
3.3. Expression of the Amfr gene
To determine the distribution of the Amfr gene expression
in normal tissues, we performed multiple tissue Northern blot
analysis of the mouse Amfr gene. A mRNA transcript of 3.5
kb was detected in the heart, brain, lung, liver, skeletal
muscle, kidney and testis. No Amfr mRNA transcript was
detected in the spleen (Fig. 3).
3.4. Chromosome mapping of the mouse Amfr gene
The human AMFR gene has been mapped to chromosome
16q21 [21]. To assign the chromosomal location of the mouse
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Amfr gene, interspeci¢c backcross analysis was performed
[14]. The Amfr locus was mapped to chromosome 8 and
tightly linked to the D8Mit11 locus (Fig. 4A and B). This
region is known to be syntenic with human chromosome
16q21.
4. Discussion
In this study, we cloned the full-length cDNAs for both
human and mouse AMFR genes. Structural analysis revealed
that the AMFR protein has a putative seven transmembrane
domain with a RING-H2 motif and a leucine zipper motif.
High levels of sequence homology between human and mouse
AMFR proteins as well as the presence of a structurally sim-
ilar sequence in C. elegans indicate that this gene is highly
conserved among di¡erent species. Expression of this gene
in diverse organs suggests that its expression plays an impor-
tant and/or common role in the maintenance of various types
of cells in di¡erent organs.
Most proteins with a seven transmembrane domain are
known as members of guanine nucleotide binding protein
(G-protein)-coupled receptors [22]. This result lends credence
to the previous ¢ndings showing that AMF interacts with a
cell surface receptor coupled with a pertussis toxin-sensitive
G-protein to initiate cell motility [23]. Interestingly, AMFR
protein possessed a RING-H2 motif and a leucine zipper mo-
tif. The RING-H2 motif is structurally similar to the RING
¢nger motif, but the fourth cysteine in the RING ¢nger motif
is replaced by histidine in the RING-H2 motif [17]. Although
many RING ¢nger proteins are reported to have DNA bind-
ing activity as in the case of zinc ¢nger proteins, it has been
suggested that most of the RING-H2 ¢nger proteins do not
bind DNA [17]. In particular, a subfamily of the RING-H2
¢nger proteins is known to be associated with the membrane.
Fig. 2. (A) Alignments of human AMFR, mouse AMFR and C. elegans F26E4.11. Black and gray boxes indicate identical and conservative
amino acids. The leucine zipper motif is denoted by asterisks. The RING-H2 motif is boxed, a N-glycosylation site is underlined and O-glyco-
sylation sites are enclosed by circles. (B) Linear arrangement of the human AMFR protein. The scale above provides amino acid numbers. The
hatched boxes indicate regions of putative transmembrane domains. The position of the RING-H2 motif is shown by a more densely hatched
box. The S symbols refer to O-glycosylation sites. (C) Hydropathy pro¢les of human AMFR and C. elegans F26E4.11. The plot was generated
by the method of Kyte and Doolittle [35]. The ordinate indicates the hydropathy index and hydrophobic and hydrophilic values are plotted
above and below the central line, respectively. The abscissa shows the amino acid numbers. (D) Alignment of the RING-H2 motif of AMFR
with those of several other proteins found in a BLAST search of the SwissProt plus PIR database [11]. Black and gray boxes indicate identical
and conservative amino acids. The number (1^6 and 1^2) below each of the conserved Cys and His refers to the potential metal binding ligands
C1^C6 and H1^H2, respectively.
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For instance, rapsyn has been implicated in the clustering and
aggregation of acetylcholine receptors and is found to be as-
sociated with the plasma membrane [24]. Neurodap1 is asso-
ciated with the cytosolic face of the membrane of the endo-
plasmic reticulum and Golgi apparatus and with the post-
synaptic region on the cytoplasmic membrane [25]. Recent
studies demonstrated that a RING-H2 motif in the yeast
Ste5 protein, which is a sca¡old for the mitogen-activated
protein kinase cascade components in a yeast pheromone re-
sponse pathway, is not only required for binding to Ste4 but
also required (directly or indirectly) for Ste5 oligomerization
[26]. Based on these observations, it has been suggested that
the RING-H2 motif is involved in a protein-protein or a
protein-lipid interaction. On the other hand, the leucine zipper
motif contains four leucyl residues repeated in every seventh
amino acid and mediates protein dimerization [27]. rZIP is a
multi-domain protein which regulates cell fate determination
during Dictyostelium development [28]. As with AMFR, rZIP
contains a RING ¢nger motif and a leucine zipper motif and
both the RING ¢nger motif and the leucine zipper motif
contribute to homodimer formation of rZIP [28]. These results
suggest that the leucine zipper motif of the AMFR protein is
involved in its homodimer formation together with the
RING-H2 motif and AMFR proteins act as a homodimer.
The identi¢cation of AMFR as a seven transmembrane
domain receptor raised the question of whether AMF belongs
to the C-C, C-X-C gene family of chemoattractants, such as
macrophage in£ammatory protein-1a/RANTES and mono-
cyte chemoattractant protein-1, and AMFR to the CXC-re-
ceptor (CXCR) gene family [29,30], since the vast majority of
CXCR proteins signal via heterotrimeric G-proteins. A ho-
mology search has revealed that AMF does not contain the
C-C or C-X-C motif and AMFR is not homologous with the
CXCR gene family. Thus, it was concluded that the C-C, C-
X-C chemokines and their receptors are di¡erent from the
AMF/AMFR. However, AMF contains a similar motif, i.e.
C-X-X-C (Cys330-Phe-Glu-Cys333). A GenBank search re-
vealed that this motif is very rare and is present only in the
disul¢de isomerase protein family as de¢ned as the thioredox-
in-box motif [31] and in one cytokine known as the macro-
phage migration inhibitor factor (MIF) [32,33]. AMF and
MIF share several structural and functional properties. Both
may be secreted by activated T-cells by a non-classical path-
way, both lack a signal peptide and both form an intramo-
lecular disul¢de bridge [4,32,33]. Since the MIF disul¢de
bridge was shown to be in the motif where its integrity is
essential for function [32] and since reducing agents inhibit
the AMF function, we question whether this C-X-X-C motif
regulates the structural integrity and function of AMF. The
comparative analysis of AMF and MIF is incomplete due to
the fact that the MIF receptor has not yet been identi¢ed. The
results presented here lay the foundation for future research
on the molecular and evolutionary signi¢cance of the AMF/
AMFR system in the further understanding of the motile
signaling pathway.
Expression of AMFR relates to cell motility-regulating ef-
fects and also may play an important role in tumor cell in-
vasion and metastasis [34]. Here, we cloned the full-length
cDNAs for both human and mouse AMFR genes. The avail-
ability of the cDNA clone containing the complete coding
region for both the human and mouse AMFR gene will now
permit detailed studies to elucidate the functional role of
AMFR in cancer invasion and metastasis.
Fig. 3. (A) Northern blot analysis of the Amfr gene in various
mouse tissues. Mouse MTN Blot (Clontech) was hybridized with an
Amfr cDNA probe. A mRNA transcript of 3.5 kb is indicated by
an arrowhead. The membrane was re-hybridized with a human L-ac-
tin probe.
Fig. 4. (A) Haplotype data of 134 progenies of (C3H/HeJUSEG)
F1UC3H/HeJ for the loci £anking the Amfr locus. The microsatel-
lite and Amfr loci are listed at the left. Each column represents a
chromosomal haplotype identi¢ed in the progenies. Filled box,
C3H/HeJ allele; open box, SEG allele. The number of progenies for
each haplotype is listed at the bottom of each column. (B) A genetic
map around the Amfr locus constructed from the haplotype data.
Recombination frequencies expressed as genetic distances in cMor-
gans are shown on the left.
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